Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Prospective, Double-masked, Randomized, Multi-center, Active Controlled, Parallel-group, 3-month Study Assessing the Safety and Ocular Hypotensive Efficacy of PG324 Ophthalmic Solution Compared to AR-13324 Ophthalmic Solution 0.02% and Latanoprost Ophthalmic Solution 0.005% in Subjects With Elevated Intraocular Pressure
Brief Summary: To evaluate ocular hypotensive efficacy and safety of PG324 Ophthalmic Solution compared to netarsudil (AR-13324) ophthalmic solution 0.02% and latanoprost ophthalmic solution 0.005%


Options:
A: Arm Label: PG324 Ophthalmic Solution 0.01%; Type: EXPERIMENTAL; Interventions: Drug: PG324 Ophthalmic Solution 0.01% | Arm Label: PG324 Ophthalmic Solution 0.02%; Type: EXPERIMENTAL; Interventions: Drug: PG324 Ophthalmic Solution 0.02% | Arm Label: Netarsudil (AR-13324) Ophthalmic Solution 0.02%; Type: ACTIVE_COMPARATOR; Interventions: Drug: Netarsudil (AR-13324) Ophthalmic Solution 0.02% | Arm Label: Latanoprost Ophthalmic Solution 0.005%; Type: ACTIVE_COMPARATOR; Interventions: Drug: Latanoprost Ophthalmic Solution 0.005% | Intervention Type: DRUG; Name: PG324 Ophthalmic Solution 0.01%; Assigned to Arm(s): PG324 Ophthalmic Solution 0.01% | Intervention Type: DRUG; Name: PG324 Ophthalmic Solution 0.02%; Assigned to Arm(s): PG324 Ophthalmic Solution 0.02% | Intervention Type: DRUG; Name: Netarsudil (AR-13324) Ophthalmic Solution 0.02%; Assigned to Arm(s): Netarsudil (AR-13324) Ophthalmic Solution 0.02% | Intervention Type: DRUG; Name: Latanoprost Ophthalmic Solution 0.005%; Assigned to Arm(s): Latanoprost Ophthalmic Solution 0.005%
B: Arm Label: PG324 Ophthalmic Solution 0.02%/0.005%; Type: EXPERIMENTAL; Interventions: Drug: PG324 Ophthalmic Solution 0.02%/0.005% | Arm Label: Netarsudil (AR-13324) ophthalmic solution 0.02%; Type: ACTIVE_COMPARATOR; Interventions: Drug: Netarsudil (AR-13324) ophthalmic solution 0.02% | Arm Label: Latanoprost ophthalmic solution 0.005%; Type: ACTIVE_COMPARATOR; Interventions: Drug: Latanoprost ophthalmic solution 0.005% | Intervention Type: DRUG; Name: PG324 Ophthalmic Solution 0.02%/0.005%; Assigned to Arm(s): PG324 Ophthalmic Solution 0.02%/0.005% | Intervention Type: DRUG; Name: Netarsudil (AR-13324) ophthalmic solution 0.02%; Assigned to Arm(s): Netarsudil (AR-13324) ophthalmic solution 0.02% | Intervention Type: DRUG; Name: Latanoprost ophthalmic solution 0.005%; Assigned to Arm(s): Latanoprost ophthalmic solution 0.005%
C: Arm Label: Netarsudil Ophthalmic Solution 0.02%; Type: EXPERIMENTAL; Interventions: Drug: Netarsudil ophthalmic solution 0.02% | Arm Label: Netarsudil Ophthalmic Solution Vehicle; Type: PLACEBO_COMPARATOR; Interventions: Other: Netarsudil Ophthalmic Solution Vehicle | Intervention Type: DRUG; Name: Netarsudil ophthalmic solution 0.02%; Assigned to Arm(s): Netarsudil Ophthalmic Solution 0.02% | Intervention Type: OTHER; Name: Netarsudil Ophthalmic Solution Vehicle; Assigned to Arm(s): Netarsudil Ophthalmic Solution Vehicle
D: Arm Label: Netarsudil; Type: EXPERIMENTAL; Interventions: Drug: Netarsudil | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Netarsudil; Assigned to Arm(s): Netarsudil | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo

Answer: B